Sinocare FCF Yield

What does Sinocare do? Sinocare Inc, listed on the Shenzhen Stock Exchange under ticker 300298.SZ, operates as a healthcare company headquartered in Changsha, China. The company went public on March 19, 2012, and currently employs 3,756 full-time staff. Sinocare focuses on the development, production, and sale of rapid detection products for chronic diseases, particularly in the field of diabetes management. Its primary offerings include micro blood glucose monitoring systems, such as blood glucose testing devices and associated test strips, as well as mobile blood glucose monitoring instruments. The company also provides diabetes management information systems to support patient care and data tracking. Sinocare distributes its products both domestically within China and internationally under the brand name SANNUO. The company's website is https://www.sinocare.com/. Sinocare's business model centers on providing accessible and reliable diagnostic tools for chronic disease management, with a strong emphasis on diabetes-related products. The company operates within the healthcare sector, specifically targeting the health care industry segment. Its operations are based in Changsha, Hunan Province, and it serves both local and global markets through its branded products. Sinocare is one of the most popular companies on Eulerpool.